Literature DB >> 3583502

Interferon alpha-2 enhances slow-wave sleep in rabbits.

J M Krueger, C A Dinarello, S Shoham, D Davenne, J Walter, S Kubillus.   

Abstract

Interferon alpha-2 (IFN) is a leukocyte product with several biological properties including antiviral activity, pyrogenicity and enhancement of immune functions. We report here that an additional facet of IFN activity is its ability to enhance slow-wave sleep (SWS) without greatly altering other aspects of sleep. Intravenous or cerebral intraventricular injections of human IFN into rabbits induced enhancement of SWS, electroencephalographic slow-wave (0.5-4 Hz) activity and brain temperatures. IFN induced slight reductions in rapid-eye movement sleep. Animal behavior, brain temperature changes that occur during the transition from one arousal state to another, and the cyclic nature of states of vigilance remained undisturbed after IFN treatment. The sleep-promoting activity of IFN may be related to feelings of lassitude and sleepiness that often accompany viral disease and interferon therapy. That IFN and other immunoactive substances, e.g. interleukin-1 and muramyl peptides, can enhance sleep suggests that sleep is linked into the immune response.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3583502     DOI: 10.1016/0192-0561(87)90107-x

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  11 in total

Review 1.  Role of biological membranes in slow-wave sleep.

Authors:  M L Karnovsky
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

2.  Somnogenic activities of synthetic lipid A.

Authors:  A B Cady; S Kotani; T Shiba; S Kusumoto; J M Krueger
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

Review 3.  Inflammatory cytokine-associated depression.

Authors:  Francis E Lotrich
Journal:  Brain Res       Date:  2014-07-05       Impact factor: 3.252

4.  Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.

Authors:  M Makino; Y Kitano; C Komiyama; M Hirohashi; K Takasuna
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 5.  Central nervous system and peripheral immune functions and the sleep-wake system.

Authors:  H Moldofsky
Journal:  J Psychiatry Neurosci       Date:  1994-11       Impact factor: 6.186

6.  Neuropsychiatric side-effects of interferon-alpha treatment: pathophysiology and therapeutic options.

Authors:  Carmen Denise Mihaela Zahiu; Mihai Rimbas
Journal:  Maedica (Buchar)       Date:  2014-06

7.  Interferon type I receptor-deficient mice have altered disease symptoms in response to influenza virus.

Authors:  Tim R Traynor; Jeannine A Majde; Stewart G Bohnet; James M Krueger
Journal:  Brain Behav Immun       Date:  2006-11-13       Impact factor: 7.217

8.  Roles of sympathetic nervous system in the suppression of cytotoxicity of splenic natural killer cells in the rat.

Authors:  T Katafuchi; S Take; T Hori
Journal:  J Physiol       Date:  1993-06       Impact factor: 5.182

9.  Role of pineal melatonin and melatonin-induced-immuno-opioids in murine leukemogenesis.

Authors:  A Conti; N Haran-Ghera; G J Maestroni
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

10.  Sleep electroencephalogram delta-frequency amplitude, night plasma levels of tumor necrosis factor alpha, and human immunodeficiency virus infection.

Authors:  D F Darko; J C Miller; C Gallen; J White; J Koziol; S J Brown; R Hayduk; J H Atkinson; J Assmus; D T Munnell; P Naitoh; J A McCutchan; M M Mitler
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.